Schnitzer TJ, et al. Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee. ACR 2018, abstract L20.
Genomische risicoscores voor juveniele idiopathische artritis
feb 2021 | JIA
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE